Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice

References

• Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:1515 - 22; http://dx.doi.org/10.1126/science.1675487; PMID: 1675487
   PubMed Web of Science ®Google Scholar
• Jendroska K, Heinzel FP, Torchia M, Stowring L, Kretzschmar HA, Kon A, et al. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 1991; 41:1482 - 90; PMID: 1679911
   PubMed Web of Science ®Google Scholar
• Schenk D, Seubert P, Ciccarelli RB. Immunotherapy w 421 ith beta-amyloid for Alzheimer's disease: a new frontier. DNA Cell Biol 2004; 20:679 - 81; http://dx.doi.org/10.1089/10445490152717532
   Web of Science ®Google Scholar
• Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T. Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer’s disease-associated pathology in transgenic mice. Am J Pathol 2001; 159:439 - 47; http://dx.doi.org/10.1016/S0002-9440(10)61715-4; PMID: 11485902
   PubMed Web of Science ®Google Scholar
• Gabizon R, McKinley MP, Groth D, Prusiner SB. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci U S A 1988; 85:6617 - 21; http://dx.doi.org/10.1073/pnas.85.18.6617; PMID: 3137571
   PubMed Web of Science ®Google Scholar
• Sigurdsson EM, Brown DR, Daniels M, Kascsak RJ, Kascsak R, Carp R, et al. Immunization delays the onset of prion disease in mice. Am J Pathol 2002; 161:13 - 7; http://dx.doi.org/10.1016/S0002-9440(10)64151-X; PMID: 12107084
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Heppner FL, Pellicioli EC, Urich E, Miele G, Braun N, et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc Natl Acad Sci U S A 2004; 101:Suppl 2 14670 - 6; http://dx.doi.org/10.1073/pnas.0404772101; PMID: 15292505
   PubMed Web of Science ®Google Scholar
• White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003; 422:80 - 3; http://dx.doi.org/10.1038/nature01457; PMID: 12621436
   PubMed Web of Science ®Google Scholar
• Müller-Schiffmann A, Korth C. Vaccine approaches to prevent and treat prion infection : progress and challenges. BioDrugs 2008; 22:45 - 52; http://dx.doi.org/10.2165/00063030-200822010-00005; PMID: 18215090
   PubMed Web of Science ®Google Scholar
• Solforosi L, Criado JR, McGavern DB, Wirz S, Sánchez-Alavez M, Sugama S, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303:1514 - 6; http://dx.doi.org/10.1126/science.1094273; PMID: 14752167
   PubMed Web of Science ®Google Scholar
• Klöhn PC, Farmer M, Linehan JM, O’Malley C, Fernandez de Marco M, Taylor W, et al. PrP antibodies do not trigger mouse hippocampal neuron apoptosis. Science 2012; 335:52; http://dx.doi.org/10.1126/science.1215579; PMID: 22223800
   PubMed Web of Science ®Google Scholar
• Campana V, Zentilin L, Mirabile I, Kranjc A, Casanova P, Giacca M, et al. Development of antibody fragments for immunotherapy of prion diseases. Biochem J 2009; 418:507 - 15; http://dx.doi.org/10.1042/BJ20081541; PMID: 19000036
   PubMed Web of Science ®Google Scholar
• Wuertzer CA, Sullivan MA, Qiu X, Federoff HJ. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset. Mol Ther 2008; 16:481 - 6; http://dx.doi.org/10.1038/sj.mt.6300387; PMID: 18180775
   PubMed Web of Science ®Google Scholar
• Burger C, Nash K, Mandel RJ. Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 2005; 16:781 - 91; http://dx.doi.org/10.1089/hum.2005.16.781; PMID: 16000060
   PubMed Web of Science ®Google Scholar
• Mandel RJ, Manfredsson FP, Foust KD, Rising A, Reimsnider S, Nash K, et al. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther 2006; 13:463 - 83; http://dx.doi.org/10.1016/j.ymthe.2005.11.009; PMID: 16412695
   PubMed Web of Science ®Google Scholar
• Guenther K, Deacon RM, Perry VH, Rawlins JN. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 2001; 14:401 - 9; http://dx.doi.org/10.1046/j.0953-816x.2001.01645.x; PMID: 11553290
   PubMed Web of Science ®Google Scholar
• Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 2006; 13:528 - 37; http://dx.doi.org/10.1016/j.ymthe.2005.11.015; PMID: 16413228
   PubMed Web of Science ®Google Scholar
• Lasmézas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275:402 - 5; http://dx.doi.org/10.1126/science.275.5298.402; PMID: 8994041
   PubMed Web of Science ®Google Scholar
• Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 1999; 18:6855 - 64; http://dx.doi.org/10.1093/emboj/18.23.6855; PMID: 10581259
   PubMed Web of Science ®Google Scholar
• Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007; 282:35878 - 86; http://dx.doi.org/10.1074/jbc.M704329200; PMID: 17923484
   PubMed Web of Science ®Google Scholar
• Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297 - 305; http://dx.doi.org/10.1042/BJ20081235; PMID: 18684106
   PubMed Web of Science ®Google Scholar
• Gauczynski S, Hundt C, Leucht C, Weiss S. Interaction of prion proteins with cell surface receptors, molecular chaperones, and other molecules. Adv Protein Chem 2001; 57:229 - 72; http://dx.doi.org/10.1016/S0065-3233(01)57024-2; PMID: 11447692
   PubMedGoogle Scholar
• Supattapone S. Biochemistry. What makes a prion infectious?. Science 2010; 327:1091 - 2; http://dx.doi.org/10.1126/science.1187790; PMID: 20185716
   PubMed Web of Science ®Google Scholar
• Akache B, Grimm D, Pandey K, Yant SR, Xu H, Kay MA. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol 2006; 80:9831 - 6; http://dx.doi.org/10.1128/JVI.00878-06; PMID: 16973587
   PubMed Web of Science ®Google Scholar
• Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2009; 27:59 - 65; http://dx.doi.org/10.1038/nbt.1515; PMID: 19098898
   PubMed Web of Science ®Google Scholar
• Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science 2002; 298:556 - 62; http://dx.doi.org/10.1126/science.298.5593.556; PMID: 12386325
   PubMed Web of Science ®Google Scholar
• Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 2011; 19:1058 - 69; http://dx.doi.org/10.1038/mt.2011.72; PMID: 21487395
   PubMed Web of Science ®Google Scholar
• Wang YJ, Gao CY, Yang M, Liu XH, Sun Y, Pollard A, et al. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer’s disease. Brain Behav Immun 2010; 24:1281 - 93; http://dx.doi.org/10.1016/j.bbi.2010.05.010; PMID: 20595065
   PubMed Web of Science ®Google Scholar
• Henriques A, Pitzer C, Dittgen T, Klugmann M, Dupuis L, Schneider A. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther 2011; 19:284 - 92; http://dx.doi.org/10.1038/mt.2010.271; PMID: 21139572
   PubMed Web of Science ®Google Scholar
• Southwell AL, Ko J, Patterson PH. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington’s disease. J Neurosci 2009; 29:13589 - 602; http://dx.doi.org/10.1523/JNEUROSCI.4286-09.2009; PMID: 19864571
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Mizuno Y. Gene therapy for Parkinson’s disease. J Neural Transm Suppl 2003; 65:205 - 13; PMID: 12946058
   PubMed Web of Science ®Google Scholar
• Muramatsu S, Fujimoto K, Kato S, Mizukami H, Asari S, Ikeguchi K, et al. A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson’s disease. Mol Ther 2010; 18:1731 - 5; http://dx.doi.org/10.1038/mt.2010.135; PMID: 20606642
   PubMed Web of Science ®Google Scholar
• Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78:6381 - 8; http://dx.doi.org/10.1128/JVI.78.12.6381-6388.2004; PMID: 15163731
   PubMed Web of Science ®Google Scholar
• Zentilin L, Marcello A, Giacca M. Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J Virol 2001; 75:12279 - 87; http://dx.doi.org/10.1128/JVI.75.24.12279-12287.2001; PMID: 11711618
   PubMed Web of Science ®Google Scholar
• Outram GW. Changes in drinking and feeding habits of mice with experimental scrapie. J Comp Pathol 1972; 82:415 - 27; http://dx.doi.org/10.1016/0021-9975(72)90041-2; PMID: 4630696
   PubMed Web of Science ®Google Scholar
• Giaccone G, Canciani B, Puoti G, Rossi G, Goffredo D, Iussich S, et al. Creutzfeldt-Jakob disease: Carnoy’s fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. Brain Pathol 2000; 10:31 - 7; http://dx.doi.org/10.1111/j.1750-3639.2000.tb00240.x; PMID: 10668893
   PubMed Web of Science ®Google Scholar
• Fraser H, Dickinson AG. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 1968; 78:301 - 11; http://dx.doi.org/10.1016/0021-9975(68)90006-6; PMID: 4970192
   PubMed Web of Science ®Google Scholar
• Taraboulos A, Jendroska K, Serban D, Yang SL, DeArmond SJ, Prusiner SB. Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A 1992; 89:7620 - 4; http://dx.doi.org/10.1073/pnas.89.16.7620; PMID: 1354357
   PubMed Web of Science ®Google Scholar